Hims & Hers Health has outperformed the market over the past 5 years by 14.14% on an annualized basis producing an average annual return of 25.67%. Currently, Hims & Hers Health has a market capitalization of $7.54 billion.

Investment Returns

If an investor had bought $100 of Hims & Hers Health stock 5 years ago, it would be worth $320.47 today based on a price of $32.56 for Hims & Hers Health at the time of writing.

Performance Metrics

The following table outlines the key performance metrics for Hims & Hers Health over the last 5 years:

The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

Hims & Hers Health Inc shares climbed after Barclays analyst Glen Santangelo reiterated an Overweight rating and lifted the price target to $39 from $29. The revised target reflects increased confidence in the company's growth trajectory, driven by improving trends in the GLP-1 segment following a partnership with Novo Nordisk A/S on March 9, 2026.

Barclays Expects Renewed Strength In GLP-1 Segment

Barclays highlighted proprietary data showing improving demand signals. Website traffic rose 12% year-over-year in April and 35% year-over-year in May. Barclaycard data indicated a 16% month-over-month increase in transactions during May, while total spending climbed 14% month-over-month.

Rating and Price Target

The analyst's decision to raise the price target suggests a stronger bullish stance on the stock's performance. The Overweight rating implies that the stock is expected to outperform the broader market or its sector peers.

HIMS Stock: Key Levels And Momentum

Hims & Hers continues to trade well above its short-term trend markers. The stock sits about 30% above the 20-day simple moving average at $27.08 and roughly 34% above the 50-day simple moving average at $26.32. It also trades about 5% above the 200-day simple moving average at $33.39.

Momentum signals remain constructive, with the MACD positioned above its signal line and a positive histogram reflecting strengthening buying pressure. However, the stock is recovering from a difficult twelve-month stretch where it fell 42.39%, and it continues to trade under the influence of a death cross that appeared in December 2025.

• Key Resistance: $36.50 — A nearby pivot zone where sellers have previously stepped in.
• Key Support: $33.00 — A short-term floor near the 200-day region.

Hims & Hers shares were up 9.94% at $35.06 at the time of publication.